About My Health Careers Internship MedBlogs Contact us

Supreme Court to Deliver Key Drug Patent Ruling

by Bidita Debnath on April 1, 2013 at 8:59 PM
Font : A-A+

 Supreme Court to Deliver Key Drug Patent Ruling

On a patent challenge by Swiss drug giant Novartis that activists say threatens access to cheap generic versions of life-saving drugs in developing nations, India's Supreme Court is set to rule.

The landmark case -- watched closely by global drug firms and patient groups -- involves an updated version of Novartis' blockbuster cancer drug Glivec, for which the company has fought a seven-year legal battle to win patent protection.


India's patent office has so far refused to grant protection, asserting that the amended form of Glivec was not vastly different from the earlier version.

The challenge strikes at the heart of India's patent law, which restricts pharmaceutical companies from seeking fresh patents for making only small modifications to existing drugs -- an industry practice known as "evergreening".

The case is the most high-profile of several patent battles being waged in India and could have far-reaching implications in defining the extent of patent protection for multinational drug firms operating in the lucrative market.

The Swiss firm has threatened to halt supplies of new medicines to India if the court does not rule in its favour, London's Financial Times reported on Sunday.

"If the situation stays as now, all improvements on an original compound are not protectable and such drugs would probably not be rolled out in India," said executive Paul Herrling, who is leading the company's handling of the case.

"Why would we?" he was quoted as saying by the newspaper.

But Leena Menghaney, a lawyer with medical charity Medecins Sans Frontieres (MSF), says a legal victory for Novartis could "set a dangerous precedent, severely weakening India's legal norms against evergreening".

It would "be dire for people in the developing world who depend on generic drugs made in this country. It could seriously curb access".

Generic drug firms in India -- long known as the "pharmacy to the developing world" -- have been a major supplier of copycat medicines to treat diseases such as cancer, TB and AIDS for those who cannot afford expensive branded versions.

The cost difference between generic and branded drugs is crucial for poor people around the world, MSF says.

It points out that Glivec -- often hailed as a "silver bullet" for its breakthrough in treating a deadly form of leukaemia -- costs $4,000 a month in its branded form while its generic version is available in India for around $73.

But Novartis and other global drugmakers say India's generics industry inhibits pharmaceutical innovation and reduces commercial incentives to produce cutting-edge medicines.

The verdict is keenly awaited by many global drug firms hoping to sell branded medicines in the nation of 1.2 billion people where the pharmaceutical market is set to touch $74 billion in sales by 2020 from $11 billion in 2011.

India's copycat drugs industry, which supplies one-fifth of the world's generics, grew into a powerhouse because the country did not issue drug patents until 2005 when it began complying with World Trade Organisation rules.

India currently allows patents only for new drugs or for an updated version of a drug that displays "enhanced" therapeutic efficiency.

Source: AFP

News A-Z
News Category
What's New on Medindia
Health Benefits of Sea Buckthorn
Contraceptive Pills in Polycystic Ovary Syndrome (PCOS) Curtail Type 2 Diabetes Risk
Mushroom May Help Cut Down the Odds of Developing Depression
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Signature Drug Toxicity 

Recommended Reading
Novel Ways to Combat Drug Resistance Discovered
A major research project conducted by University of Southampton biological scientists is aimed at .....
Study Finds Damage Caused to DNA by Some Teas and Coffees is Comparable to Chemo Drugs
A new study found that black and green teas and coffee along with liquid smoke produced cell DNA ......
Indians Overtake Iranians and Nigerians as Top Drug Smugglers in Malaysia
Malaysian officials believe that Indian nationals have overtaken Iranian and Nigerian syndicates as ...
Diabetes Drug Delays Ageing in Worms
In worms, a type 2 diabetes drug slows down the ageing process, states study....
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use